GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Health Group Inc (HKSE:08225) » Definitions » Cyclically Adjusted PS Ratio

China Health Group (HKSE:08225) Cyclically Adjusted PS Ratio : (As of Jun. 04, 2025)


View and export this data going back to 2003. Start your Free Trial

What is China Health Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


China Health Group Cyclically Adjusted PS Ratio Historical Data

The historical data trend for China Health Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group Cyclically Adjusted PS Ratio Chart

China Health Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.55 6.49 - 2.34 -

China Health Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.06 2.49 2.34 - -

Competitive Comparison of China Health Group's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, China Health Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Group's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where China Health Group's Cyclically Adjusted PS Ratio falls into.


;
;

China Health Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

China Health Group's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, China Health Group's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/114.8925*114.8925
=0.000

Current CPI (Dec. 2024) = 114.8925.

China Health Group Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.004 98.200 0.005
201409 0.007 98.900 0.008
201503 0.001 99.900 0.001
201506 0.005 99.500 0.006
201509 0.003 100.500 0.003
201512 0.017 100.600 0.019
201603 0.008 102.200 0.009
201606 0.010 101.400 0.011
201609 0.003 102.400 0.003
201612 0.003 102.600 0.003
201703 0.009 103.200 0.010
201706 0.009 103.100 0.010
201709 0.014 104.100 0.015
201712 0.036 104.500 0.040
201803 0.019 105.300 0.021
201806 0.020 104.900 0.022
201809 0.011 106.600 0.012
201812 0.024 106.500 0.026
201903 0.019 107.700 0.020
201906 0.017 107.700 0.018
201909 0.009 109.800 0.009
201912 0.026 111.200 0.027
202003 0.024 112.300 0.025
202006 0.023 110.400 0.024
202009 0.011 111.700 0.011
202012 0.037 111.500 0.038
202103 0.031 112.662 0.032
202106 0.027 111.769 0.028
202109 0.009 112.215 0.009
202112 0.034 113.108 0.035
202203 0.018 114.335 0.018
202206 0.019 114.558 0.019
202209 0.003 115.339 0.003
202212 0.000 115.116 0.000
202303 0.005 115.116 0.005
202306 0.012 114.558 0.012
202309 0.003 115.339 0.003
202312 0.004 114.781 0.004
202406 0.000 114.781 0.000
202412 0.000 114.893 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Health Group  (HKSE:08225) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


China Health Group Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of China Health Group's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Group Business Description

Traded in Other Exchanges
N/A
Address
Building 17, Jianwai SOHO, Chaoyang District, Beijing, CHN
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's Republic of China. The company provides provision of post-launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), drug technologies, and Other medical services. The majority of the revenue for the company comes from the provision of PM services.
Executives
Guo Xia 2101 Beneficial owner
Winsland Agents Limited 2101 Beneficial owner

China Health Group Headlines

No Headlines